Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases
Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases
Get summaries like this every morning.
Free AI-powered recaps of The Long Run with Luke Timmerman and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.